Synjardy side effects can include stomach upset, diarrhea, nausea, urinary tract infections, genital yeast infections, headache, weakness, and low blood sugar, especially when used with insulin or a sulfonylurea. Rare but serious reactions can include lactic acidosis, ketoacidosis, severe dehydration, kidney problems, serious urinary or genital infections, and allergic reactions. Because Synjardy combines empagliflozin and metformin, symptoms can come from either medicine. Recognizing patterns early helps you document concerns and seek care without changing treatment on your own.
This article covers Synjardy and Synjardy XR at a safety level. It does not replace the medication guide, product label, or instructions from your prescriber.
Key Takeaways
- Synjardy side effects are often gastrointestinal, urinary, or genital.
- Some mild stomach symptoms may settle, but infections need review.
- Lactic acidosis and ketoacidosis symptoms need urgent medical attention.
- Low blood sugar risk can rise with insulin or sulfonylureas.
- Do not stop or change diabetes medicines without clinical guidance.
Why Synjardy Side Effects Can Look Different
Synjardy can cause varied symptoms because it combines two glucose-lowering medicines with different effects. Empagliflozin belongs to the sodium-glucose cotransporter 2, or SGLT2, inhibitor class. These medicines help the kidneys remove extra glucose through urine. That mechanism can contribute to genital yeast infections, urinary symptoms, increased urination, and fluid loss in some people. For broader class context, see SGLT2 Inhibitors Explained.
Metformin is a biguanide, a medicine class that helps reduce glucose production by the liver and improves insulin sensitivity. Its most familiar side effects involve the digestive tract. Nausea, diarrhea, gas, and stomach discomfort may be linked to the metformin component. For a deeper look at this ingredient, read Metformin for Type 2 Diabetes.
Synjardy XR side effects generally overlap with the immediate-release product because both contain empagliflozin and metformin. The extended-release form changes how metformin is released, but it does not remove the core safety issues. Kidney function, hydration, other diabetes medicines, alcohol use, infections, and planned procedures can all affect risk. That is why side effects should be interpreted in the context of your full medication list and health history.
Common Synjardy Side Effects and How They May Feel
Most Synjardy side effects reported early are stomach, urinary, or genital symptoms. They can be uncomfortable, but the meaning depends on severity, timing, and whether other warning signs appear. A symptom diary can help your clinician see patterns, especially if symptoms began after a dose change or another medication was added.
| Symptom Pattern | How It May Present | When to Contact a Clinician |
|---|---|---|
| Diarrhea or nausea | Loose stools, queasiness, gas, indigestion, or stomach discomfort. | If symptoms are severe, persistent, bloody, or linked with dehydration. |
| Urinary symptoms | Burning, urgency, frequent urination, pelvic discomfort, or cloudy urine. | If fever, back pain, blood in urine, or worsening symptoms appear. |
| Genital yeast symptoms | Itching, burning, redness, swelling, discharge, or genital discomfort. | If symptoms are new, severe, recurrent, or spreading. |
| Headache or weakness | Low energy, lightheadedness, mild headache, or feeling run down. | If weakness is intense, sudden, or paired with breathing or confusion. |
| Low blood sugar | Shaking, sweating, hunger, fast heartbeat, anxiety, or confusion. | If episodes repeat, are severe, or occur with insulin or sulfonylureas. |
Diarrhea and nausea deserve attention because they can reduce fluid intake. Fluid loss matters more if you also have fever, vomiting, poor appetite, or hot-weather exposure. Persistent diarrhea can also interfere with usual eating patterns, which may complicate glucose management.
Urinary tract infections can affect anyone taking this medicine. Symptoms may include burning with urination, urgency, lower abdominal discomfort, or urine that looks cloudy or smells different. Fever, chills, flank pain, or feeling very unwell may suggest a more serious infection and should not be ignored.
Genital yeast infections are also important to recognize. In females, symptoms may include vulvar itching, burning, soreness, redness, or vaginal discharge. In males, symptoms may include redness, itching, swelling, pain around the penis, or discharge. Recurrent infections are worth discussing, even when each episode seems mild.
Symptoms That May Settle Versus Symptoms That Need Care
Some mild gastrointestinal symptoms may improve after the body adjusts, but that is not guaranteed. Infections usually need diagnosis and appropriate treatment. Symptoms such as severe vomiting, trouble breathing, confusion, fainting, intense weakness, or severe abdominal pain should be treated as urgent rather than watched for several days.
A practical question is whether the pattern is improving, stable, or worsening. Mild nausea that steadily improves differs from nausea with rapid breathing, dehydration, or abdominal pain. If you are unsure, it is safer to contact a clinician or pharmacist for guidance than to guess.
Hair Loss Is Not a Typical Label-Highlighted Effect
Hair loss is not usually highlighted as a common label-listed effect of empagliflozin/metformin. That does not mean hair changes should be dismissed. Thyroid disease, iron deficiency, stress, nutritional changes, high glucose, weight changes, and other medicines can contribute. If hair shedding is sudden, patchy, or persistent, ask a clinician to look for other causes rather than assuming the medication is the only explanation.
Serious Synjardy Side Effects and Warning Signs
Serious Synjardy side effects are less common, but they can progress quickly. The main safety concern is recognizing when symptoms point beyond routine stomach upset or a simple infection. Seek urgent medical attention for symptoms suggesting lactic acidosis, ketoacidosis, a severe infection, dehydration, kidney problems, or an allergic reaction.
- Lactic acidosis: severe weakness, unusual sleepiness, muscle pain, trouble breathing, stomach pain with nausea, dizziness, slow heartbeat, or feeling cold.
- Ketoacidosis: nausea, vomiting, abdominal pain, tiredness, trouble breathing, fruity-smelling breath, or confusion.
- Severe dehydration: fainting, marked dizziness, very low fluid intake, or much less urination.
- Serious urinary infection: fever, chills, flank pain, pelvic pain, or feeling very ill.
- Severe genital infection: genital or perineal pain, swelling, redness, fever, or rapidly worsening tenderness.
- Allergic reaction: hives, swelling of the lips, tongue, or throat, wheezing, or trouble breathing.
Why it matters: SGLT2-related ketoacidosis may occur with lower-than-expected glucose readings.
Lactic acidosis is a rare but serious metformin-associated risk. Risk may rise with kidney problems, severe dehydration, heavy alcohol use, severe infection, low oxygen states, certain procedures, or serious illness. For more context, see Lactic Acidosis and Metformin.
Ketoacidosis is a buildup of acidic ketones in the blood. It is often linked with diabetes, acute illness, reduced food intake, dehydration, surgery, or insulin deficiency. People using SGLT2 inhibitors should take nausea, vomiting, abdominal pain, or breathing changes seriously, even if a glucose reading is not extremely high.
Severe genital or urinary infections are also warning-sign conditions. Rare cases of a serious infection around the genitals and perineum have been reported with SGLT2 inhibitors. Any rapidly worsening genital pain, swelling, redness, fever, or feeling very ill needs prompt medical assessment.
Blood Sugar Changes and Sick-Day Clues
Synjardy can affect glucose patterns, especially when combined with other diabetes medicines. Low blood sugar is more likely when empagliflozin/metformin is used with insulin or medicines that increase insulin release, such as sulfonylureas. Symptoms may include shakiness, sweating, hunger, fast heartbeat, tingling, anxiety, confusion, drowsiness, or fainting.
Use your own diabetes care plan for treating low readings. If episodes repeat, happen overnight, or occur during illness, your clinician may need to review the full regimen. Do not reduce or stop medicines on your own to prevent lows. For general number interpretation, see the Blood Sugar Normal Range Chart.
If readings are recorded in different units, this converter helps translate blood glucose values between mg/dL and mmol/L. It does not interpret symptoms or replace clinical guidance.
Blood Glucose Unit Converter
Convert glucose readings between mg/dL and mmol/L without changing the clinical value.
These calculations are for education only and do not replace clinical advice, diagnosis, or treatment. Always confirm medical decisions with a qualified healthcare professional.
Illness can make side effects harder to interpret. Vomiting, diarrhea, fever, poor intake, and dehydration can increase safety concerns with diabetes medicines. Imaging with contrast dye, surgery, or acute illness may require specific prescriber instructions. If high glucose symptoms appear with dehydration, abdominal pain, or breathing changes, review High Blood Sugar Symptoms and seek care according to severity.
What to Avoid or Review Before Problems Build
The most important thing to avoid is making medication changes without clinical input. Several habits and situations can also raise the chance of side effects or make them harder to manage. These points are not personal rules for every patient, but they are useful topics to review with a prescriber or pharmacist.
- Heavy alcohol use: may raise metformin-related lactic acidosis concerns.
- Dehydration: worsens dizziness, kidney strain, and illness-related risk.
- Prolonged fasting: can complicate glucose control and ketone risk.
- Very low carbohydrate diets: should be discussed before major changes.
- Unreviewed new medicines: some affect kidneys, fluids, or glucose.
- Ignored infection symptoms: urinary or genital infections may need treatment.
- Missed lab monitoring: kidney function and vitamin B12 may need review.
Pregnancy, plans to become pregnant, or breastfeeding also need clinician review because product labeling includes specific cautions. The same applies if you have kidney disease, liver disease, recurrent urinary infections, recurrent genital yeast infections, heavy alcohol intake, or a history of ketoacidosis.
Quick tip: Bring a written symptom timeline to medication reviews.
Include when symptoms started, whether they followed missed meals or illness, and whether glucose readings changed. Also list non-prescription products, supplements, and recent antibiotics. This helps the care team separate medication-related symptoms from infection, dehydration, diet changes, or another medical condition.
If Synjardy Is Not a Good Fit
A replacement for Synjardy is not one-size-fits-all. A clinician may consider the separate ingredients, a different SGLT2 inhibitor, another metformin strategy, a GLP-1 receptor agonist, a DPP-4 inhibitor, insulin, or another combination. The choice depends on glucose goals, kidney function, cardiovascular and kidney history, tolerability, other medicines, and personal risk factors.
If Synjardy side effects are persistent or unsafe, the next step is a medication review rather than a direct swap. Combination products can be convenient, but they make it harder to tell which ingredient is causing a problem. A clinician may separate the components or choose a different class to clarify tolerability. For broader decision factors, see Diabetes Medication Combinations.
When comparing related options, it helps to understand the wider class. The SGLT2 Inhibitor Drug Names resource explains examples in the class, while GLP-1 Explained covers another medication group sometimes used in type 2 diabetes care. For browsing by condition, the Type 2 Diabetes hub groups related educational resources.
For access discussions, CanadianInsulin.com is a prescription referral platform, so clinical changes still need prescriber input. Bring side effect notes, glucose logs, and recent lab results to the conversation when available. Those details often matter more than the medication name alone.
Authoritative Sources
These references support the safety framing and warning-sign language used above.
- For label-backed patient details, review the DailyMed Synjardy Medication Guide.
- For Canadian product status details, see the Health Canada Drug Product Register.
- For prescribing warnings and precautions, see the FDA Prescribing Information for Synjardy.
This content is for informational purposes only and is not a substitute for professional medical advice.
